Evidence map›Paper›PMID 37208626›Full record

ArticleBMC gastroenterology2023

Trend analysis of hepatitis B and C among patients visiting health facility of Tigrai, Ethiopia, 2014-2019.

Haftom Legese, Brhane Berhe, Gebre Adhanom, Tsega Kahsay, Aderajew Gebrewahd, Guesh Gebremariam, Fitsum Mardu, Kebede Tesfay, Haftay Gebremedhin, Hadush Negash

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Haftom LegeseDepartment of Medical Laboratory, College of Health Sciences, Adigrat University, Adigrat City, Tigrai, Ethiopia. legesehaftom2@gmail.com.
Brhane BerheDepartment of Medical Laboratory, College of Health Sciences, Adigrat University, Adigrat City, Tigrai, Ethiopia.
Gebre AdhanomDepartment of Medical Laboratory, College of Health Sciences, Adigrat University, Adigrat City, Tigrai, Ethiopia.
Tsega KahsayDepartment of Medical Laboratory, College of Health Sciences, Adigrat University, Adigrat City, Tigrai, Ethiopia.
Aderajew GebrewahdDepartment of Medical Laboratory, College of Health Sciences, Adigrat University, Adigrat City, Tigrai, Ethiopia.
Guesh GebremariamDepartment of Medical Laboratory, College of Health Sciences, Adigrat University, Adigrat City, Tigrai, Ethiopia.
Fitsum MarduDepartment of Medical Laboratory, College of Health Sciences, Adigrat University, Adigrat City, Tigrai, Ethiopia.
Kebede TesfayDepartment of Medical Laboratory, College of Health Sciences, Adigrat University, Adigrat City, Tigrai, Ethiopia.
Haftay GebremedhinDepartment of Public Health, College of Health Sciences, Adigrat University, Adigrat City, Tigrai, Ethiopia.
Hadush NegashDepartment of Medical Laboratory, College of Health Sciences, Adigrat University, Adigrat City, Tigrai, Ethiopia.
Adigrat University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis B and C viruses are the major public health concerns of the globe. The two hepatotropic viruses share common modes of transmission and their co-infection is common. Despite the provision of an effective prevention mechanism, the infections caused by these viruses remain a significant problem worldwide, particularly among developing countries like Ethiopia.

methodsThis institutional-based retrospective study was conducted between January 2014 December and December 2019 from documented laboratory logbooks of Adigrat general hospital serology laboratory, Tigrai, Ethiopia. data were collected and checked for completeness on a daily based, coded, entered, and cleaned using Epinfo version 7.1, exported and analyzed using SPSS version 23. Binary logistic regression analysis and Chi-square test (X

resultsOut of 20,935 clinically suspected individuals, 20,622 were given specimens and tested for hepatitis B and C viruses with total completeness of 98.5%. The overall prevalence of hepatitis B and hepatitis C virus was found to be 3.57% (689/19,273) and 2.13% (30/1,405), respectively. The positivity rate of the hepatitis B virus was 8.0% (106/1317) and 3.24% (583/17,956) among males and females, respectively. Additionally, 2.49%( 12/481) of males and 1.94% (18/924) of females were positive for hepatitis C virus infection. The overall prevalence of co-infection for both hepatitis B and hepatitis C virus was 7.4% (4/54). Sex and age were significantly associated with hepatitis B and C virus infection.

conclusionsThe overall prevalence of hepatitis B and C is low intermediate according to the WHO criteria. Although there was a fluctuating trend of hepatitis B and C through the years 2014-2019, the result shows moreover declining trend. Both hepatitis B and C share similar routes of transmission and affect all age categories but males were more highly affected than females. Therefore, awareness creation of the community about the methods of transmission, education about prevention, and control of hepatitis B and C virus infection, and improving coverage of youth-friendly services in health facilities should be strengthened.

Indexed as

CoinfectionHepatitis BHepatitis CAdolescentEthiopiaFemaleHealth FacilitiesHepacivirusHumansMaleRetrospective StudiesRisk FactorsSeroepidemiologic StudiesEthiopiaHepatitis BHepatitis C virusTigraiTrend

Identifiers

PMID37208626
PMCPMC10196286
OpenAlexW4377097067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.